Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,305 public trials 1,294 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Completed

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer

NCT04208958

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +28 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Pacific Hematology Oncology Associates San Francisco, California, United States
  • The Angeles Clinic and Research Institute - West Los Angeles Office Santa Monica, California, United States
View all 18 locations
View Trial Details
Completed

Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)

NCT04303169

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • The Angeles Clinic and Research Institute ( Site 3009) Los Angeles, California, United States
  • Providence Saint John's Health Center ( Site 3010) Santa Monica, California, United States
  • University of Colorado, Anschutz Cancer Pavilion ( Site 3012) Aurora, Colorado, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 3022) Baltimore, Maryland, United States
View all 29 locations
View Trial Details
Completed

A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors

NCT05091346

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, Irvine Health Orange, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • SCRI Florida Cancer Specialists East West Palm Beach, Florida, United States
View all 32 locations
View Trial Details
Completed

ASP8374 + Cemiplimab in Recurrent Glioma

NCT04826393

Conditions
Astrocytoma, Glioblastoma, Glioma, +16 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • University of Cincinnati Medical Center Cincinnati, Ohio, United States
  • Hospital of the University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)

NCT05665595

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • Moores Cancer Center ( Site 0116) La Jolla, California, United States
  • The Angeles Clinic and Research Institute - West Los Angeles Office ( Site 0123) Los Angeles, California, United States
  • UCLA Hematology/Oncology - Westwood (Building 100) ( Site 0131) Los Angeles, California, United States
  • California Pacific Medical Center - Pacific Campus ( Site 0111) San Francisco, California, United States
View all 205 locations
View Trial Details
Completed

A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

NCT05293496

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details
Completed

Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea

NCT00807027

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Hanyang University Guri Hospital Guri-si, Gyeonggi-do, South Korea
  • Gyunghee University Medical Center Seoul, South Korea
  • Konkuk University Seoul, South Korea
  • Korea University Anam Hospital Seoul, South Korea
View Trial Details

Related conditions